Clinical trials
Active, not recruiting Leukemia, Myeloid, Acute trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 3 |
| AbbVie | 2 |
| Daiichi Sankyo | 2 |
| Janssen Research & Development, LLC | 2 |
| National Cancer Institute (NCI) | 2 |
| Novartis Pharmaceuticals | 2 |
| OncoVerity, Inc. | 2 |
| Actinium Pharmaceuticals | 1 |
| Celgene | 1 |
| Donald Arnold | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 25 |
| Myelodysplastic Syndromes | 6 |
| Leukemia | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Hematologic Neoplasms | 2 |
| Leukemia, Biphenotypic, Acute | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Myeloproliferative Disorders | 2 |
| Recurrence | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.